Psychiatry & Neurology Doctors in Poulsbo, WA Accepting Medicare

7 Psychiatry & Neurology doctors found. Showing 1 - 7

Dr. Lorin Debora Boynton, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 19041 Front St Ne, Poulsbo, WA 98370 Phone: 206-852-8870

Christina Anne Hughes, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 17791 Fjord Dr Ne Ste 110, Poulsbo, WA 98370 Phone: 206-512-4846    Fax: 425-412-8136

Linda Diane Swartz, M.D. Psychiatry & Neurology - Neurology Medicare: Not Enrolled in Medicare Practice Location: 20730 Bond Rd Ne, Suite 201, Poulsbo, WA 98370 Phone: 360-697-4557    Fax: 360-697-4007

Dr. Michael S. Burke, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 19980 10th Ave Ne, Ste 204f, Poulsbo, WA 98370 Phone: 360-779-4807    Fax: 360-779-5613

Dr. Frank Anthony Stanton, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 17300 Viking Way Nw, Poulsbo, WA 98370 Phone: 360-981-4045    Fax: 360-697-3423

Dr. Anselm A Parlatore, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 20301 Bond Rd #150, Poulsbo, WA 98370 Phone: 360-739-9865    Fax: 360-881-0810

Terence F. Mcguire, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 674 Ne Harrison St, Poulsbo, WA 98370 Phone: 360-779-6153

News Archive

Stem cells may 'ignite' bowel cancer development

Cancer Research UK scientists have discovered for the first time that stem cells could be the root cause of bowel cancer, according to a study published in Nature.

New Haven Pharmaceuticals' DURLAZA drug delivers sustained antiplatelet control for full 24 hours

New Haven Pharmaceuticals, Inc. today announced new study data that shows the company's FDA-approved drug DURLAZA delivers sustained antiplatelet control for a full 24-hour period in high-risk patients.

Study reports children with chronic kidney disease may spend more time in hospital

Chronically ill children with kidney disease may spend more time in the hospital, incur larger health care costs, and have a higher risk of death compared to pediatric patients hospitalized for other chronic conditions, a new study suggests.

BodyGuard wearable patch product shows superiority to common NSAID treatments in restoring joint function

Perth skin science technology company OBJ Limited is set to revolutionise treatment of joint injuries and osteoarthritis after its BodyGuard wearable patch product proved its superiority to the world-leading non-steroidal anti-inflammatory drug product Voltaren.

Read more Medical News

› Verified 7 days ago